Cellino’s purpose is to build a precision platform that personalizes human cells for all, focusing on Parkinson’s, diabetes and heart disease. Cellino’s platform combines label-free imaging and high-speed laser editing with machine learning to automate cell reprogramming, expansion and differentiation in a closed cassette format, enabling thousands of patient samples to be processed in parallel in a single facility.